SHARE CAPITAL - Summary of stock option information (Details) $ in Thousands |
12 Months Ended |
|
|
|
|
Mar. 31, 2026
shares
|
Mar. 31, 2026
USD ($)
|
Mar. 31, 2026
option
|
Mar. 31, 2026
$ / shares
|
Mar. 31, 2025
shares
|
Mar. 31, 2024
shares
|
| Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] |
|
|
|
|
|
|
| Number of share options outstanding (in shares) |
3,978,282
|
|
3,978,282
|
|
3,956,684
|
1,742,139
|
| Number of options exercisable (in shares) |
3,671,060
|
|
3,671,060
|
|
|
|
| Estimated grant date fair value | $ |
|
$ 31,563
|
|
|
|
|
| Weighted average remaining life |
7 years 7 months 6 days
|
|
|
|
|
|
| Option Expiration Period One |
|
|
|
|
|
|
| Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] |
|
|
|
|
|
|
| Number of share options outstanding (in shares) |
|
|
658
|
|
|
|
| Number of options exercisable (in shares) |
|
|
658
|
|
|
|
| Exercise price (in USD per share) | $ / shares |
|
|
|
$ 13.11
|
|
|
| Estimated grant date fair value | $ |
|
5
|
|
|
|
|
| Weighted average remaining life |
2 months 8 days
|
|
|
|
|
|
| Option Expiration Period Two |
|
|
|
|
|
|
| Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] |
|
|
|
|
|
|
| Number of share options outstanding (in shares) |
|
|
3,816
|
|
|
|
| Number of options exercisable (in shares) |
|
|
3,816
|
|
|
|
| Exercise price (in USD per share) | $ / shares |
|
|
|
16.72
|
|
|
| Estimated grant date fair value | $ |
|
35
|
|
|
|
|
| Weighted average remaining life |
2 months 8 days
|
|
|
|
|
|
| Option Expiration Period Three |
|
|
|
|
|
|
| Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] |
|
|
|
|
|
|
| Number of share options outstanding (in shares) |
|
|
1,974
|
|
|
|
| Number of options exercisable (in shares) |
|
|
1,974
|
|
|
|
| Exercise price (in USD per share) | $ / shares |
|
|
|
21.28
|
|
|
| Estimated grant date fair value | $ |
|
21
|
|
|
|
|
| Weighted average remaining life |
2 months 8 days
|
|
|
|
|
|
| Option Expiration Period Four |
|
|
|
|
|
|
| Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] |
|
|
|
|
|
|
| Number of share options outstanding (in shares) |
|
|
2,436
|
|
|
|
| Number of options exercisable (in shares) |
|
|
2,436
|
|
|
|
| Exercise price (in USD per share) | $ / shares |
|
|
|
14.37
|
|
|
| Estimated grant date fair value | $ |
|
21
|
|
|
|
|
| Weighted average remaining life |
2 months 8 days
|
|
|
|
|
|
| Option Expiration Period Five |
|
|
|
|
|
|
| Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] |
|
|
|
|
|
|
| Number of share options outstanding (in shares) |
|
|
2,375
|
|
|
|
| Number of options exercisable (in shares) |
|
|
2,375
|
|
|
|
| Exercise price (in USD per share) | $ / shares |
|
|
|
14.37
|
|
|
| Estimated grant date fair value | $ |
|
20
|
|
|
|
|
| Weighted average remaining life |
2 months 26 days
|
|
|
|
|
|
| Option Expiration Period Six |
|
|
|
|
|
|
| Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] |
|
|
|
|
|
|
| Number of share options outstanding (in shares) |
|
|
2,501
|
|
|
|
| Number of options exercisable (in shares) |
|
|
2,501
|
|
|
|
| Exercise price (in USD per share) | $ / shares |
|
|
|
110.20
|
|
|
| Estimated grant date fair value | $ |
|
138
|
|
|
|
|
| Weighted average remaining life |
2 months 26 days
|
|
|
|
|
|
| Option Expiration Period Seven |
|
|
|
|
|
|
| Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] |
|
|
|
|
|
|
| Number of share options outstanding (in shares) |
|
|
25,657
|
|
|
|
| Number of options exercisable (in shares) |
|
|
25,657
|
|
|
|
| Exercise price (in USD per share) | $ / shares |
|
|
|
30.02
|
|
|
| Estimated grant date fair value | $ |
|
306
|
|
|
|
|
| Weighted average remaining life |
5 months 26 days
|
|
|
|
|
|
| Option Expiration Period Eight |
|
|
|
|
|
|
| Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] |
|
|
|
|
|
|
| Number of share options outstanding (in shares) |
|
|
13,158
|
|
|
|
| Number of options exercisable (in shares) |
|
|
13,158
|
|
|
|
| Exercise price (in USD per share) | $ / shares |
|
|
|
27.17
|
|
|
| Estimated grant date fair value | $ |
|
110
|
|
|
|
|
| Weighted average remaining life |
7 months 17 days
|
|
|
|
|
|
| Option Expiration Period Nine |
|
|
|
|
|
|
| Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] |
|
|
|
|
|
|
| Number of share options outstanding (in shares) |
|
|
1,842
|
|
|
|
| Number of options exercisable (in shares) |
|
|
1,842
|
|
|
|
| Exercise price (in USD per share) | $ / shares |
|
|
|
13.11
|
|
|
| Estimated grant date fair value | $ |
|
15
|
|
|
|
|
| Weighted average remaining life |
9 months
|
|
|
|
|
|
| Option Expiration Period Ten |
|
|
|
|
|
|
| Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] |
|
|
|
|
|
|
| Number of share options outstanding (in shares) |
|
|
3,947
|
|
|
|
| Number of options exercisable (in shares) |
|
|
3,947
|
|
|
|
| Exercise price (in USD per share) | $ / shares |
|
|
|
16.72
|
|
|
| Estimated grant date fair value | $ |
|
37
|
|
|
|
|
| Weighted average remaining life |
9 months
|
|
|
|
|
|
| Option Expiration Period Eleven |
|
|
|
|
|
|
| Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] |
|
|
|
|
|
|
| Number of share options outstanding (in shares) |
|
|
1,974
|
|
|
|
| Number of options exercisable (in shares) |
|
|
1,974
|
|
|
|
| Exercise price (in USD per share) | $ / shares |
|
|
|
21.28
|
|
|
| Estimated grant date fair value | $ |
|
21
|
|
|
|
|
| Weighted average remaining life |
9 months
|
|
|
|
|
|
| Option Expiration Period Twelve |
|
|
|
|
|
|
| Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] |
|
|
|
|
|
|
| Number of share options outstanding (in shares) |
|
|
32,896
|
|
|
|
| Number of options exercisable (in shares) |
|
|
32,896
|
|
|
|
| Exercise price (in USD per share) | $ / shares |
|
|
|
57.00
|
|
|
| Estimated grant date fair value | $ |
|
940
|
|
|
|
|
| Weighted average remaining life |
9 months
|
|
|
|
|
|
| Option Expiration Period Thirteen |
|
|
|
|
|
|
| Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] |
|
|
|
|
|
|
| Number of share options outstanding (in shares) |
|
|
526
|
|
|
|
| Number of options exercisable (in shares) |
|
|
526
|
|
|
|
| Exercise price (in USD per share) | $ / shares |
|
|
|
42.94
|
|
|
| Estimated grant date fair value | $ |
|
11
|
|
|
|
|
| Weighted average remaining life |
11 months 4 days
|
|
|
|
|
|
| Option Expiration Period Fourteen |
|
|
|
|
|
|
| Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] |
|
|
|
|
|
|
| Number of share options outstanding (in shares) |
|
|
10,526
|
|
|
|
| Number of options exercisable (in shares) |
|
|
10,526
|
|
|
|
| Exercise price (in USD per share) | $ / shares |
|
|
|
38.76
|
|
|
| Estimated grant date fair value | $ |
|
205
|
|
|
|
|
| Weighted average remaining life |
11 months 8 days
|
|
|
|
|
|
| Option Expiration Period Fifteen |
|
|
|
|
|
|
| Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] |
|
|
|
|
|
|
| Number of share options outstanding (in shares) |
|
|
248,607
|
|
|
|
| Number of options exercisable (in shares) |
|
|
248,607
|
|
|
|
| Exercise price (in USD per share) | $ / shares |
|
|
|
16.72
|
|
|
| Estimated grant date fair value | $ |
|
2,308
|
|
|
|
|
| Weighted average remaining life |
2 years 3 months
|
|
|
|
|
|
| Option Expiration Period Sixteen |
|
|
|
|
|
|
| Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] |
|
|
|
|
|
|
| Number of share options outstanding (in shares) |
|
|
2,632
|
|
|
|
| Number of options exercisable (in shares) |
|
|
2,632
|
|
|
|
| Exercise price (in USD per share) | $ / shares |
|
|
|
30.02
|
|
|
| Estimated grant date fair value | $ |
|
41
|
|
|
|
|
| Weighted average remaining life |
2 years 5 months 26 days
|
|
|
|
|
|
| Option Expiration Period Seventeen |
|
|
|
|
|
|
| Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] |
|
|
|
|
|
|
| Number of share options outstanding (in shares) |
|
|
526
|
|
|
|
| Number of options exercisable (in shares) |
|
|
526
|
|
|
|
| Exercise price (in USD per share) | $ / shares |
|
|
|
21.28
|
|
|
| Estimated grant date fair value | $ |
|
6
|
|
|
|
|
| Weighted average remaining life |
2 years 11 months 19 days
|
|
|
|
|
|
| Option Expiration Period Eighteen |
|
|
|
|
|
|
| Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] |
|
|
|
|
|
|
| Number of share options outstanding (in shares) |
|
|
226,977
|
|
|
|
| Number of options exercisable (in shares) |
|
|
226,977
|
|
|
|
| Exercise price (in USD per share) | $ / shares |
|
|
|
21.28
|
|
|
| Estimated grant date fair value | $ |
|
2,366
|
|
|
|
|
| Weighted average remaining life |
3 years 3 days
|
|
|
|
|
|
| Option Expiration Period Nineteen |
|
|
|
|
|
|
| Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] |
|
|
|
|
|
|
| Number of share options outstanding (in shares) |
|
|
7,895
|
|
|
|
| Number of options exercisable (in shares) |
|
|
7,895
|
|
|
|
| Exercise price (in USD per share) | $ / shares |
|
|
|
34.20
|
|
|
| Estimated grant date fair value | $ |
|
124
|
|
|
|
|
| Weighted average remaining life |
6 years 3 months
|
|
|
|
|
|
| Option Expiration Period Twenty |
|
|
|
|
|
|
| Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] |
|
|
|
|
|
|
| Number of share options outstanding (in shares) |
|
|
2,886,389
|
|
|
|
| Number of options exercisable (in shares) |
|
|
2,879,763
|
|
|
|
| Exercise price (in USD per share) | $ / shares |
|
|
|
13.11
|
|
|
| Estimated grant date fair value | $ |
|
22,836
|
|
|
|
|
| Weighted average remaining life |
8 years 4 months 17 days
|
|
|
|
|
|
| Option Expiration Period Twenty One |
|
|
|
|
|
|
| Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] |
|
|
|
|
|
|
| Number of share options outstanding (in shares) |
|
|
64,500
|
|
|
|
| Number of options exercisable (in shares) |
|
|
48,717
|
|
|
|
| Exercise price (in USD per share) | $ / shares |
|
|
|
14.37
|
|
|
| Estimated grant date fair value | $ |
|
516
|
|
|
|
|
| Weighted average remaining life |
8 years 7 months 28 days
|
|
|
|
|
|
| Option Expiration Period Twenty Two |
|
|
|
|
|
|
| Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] |
|
|
|
|
|
|
| Number of share options outstanding (in shares) |
|
|
35,000
|
|
|
|
| Number of options exercisable (in shares) |
|
|
35,000
|
|
|
|
| Exercise price (in USD per share) | $ / shares |
|
|
|
10.45
|
|
|
| Estimated grant date fair value | $ |
|
214
|
|
|
|
|
| Weighted average remaining life |
8 years 11 months 4 days
|
|
|
|
|
|
| Option Expiration Period Twenty Three |
|
|
|
|
|
|
| Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] |
|
|
|
|
|
|
| Number of share options outstanding (in shares) |
|
|
48,800
|
|
|
|
| Number of options exercisable (in shares) |
|
|
18,294
|
|
|
|
| Exercise price (in USD per share) | $ / shares |
|
|
|
10.00
|
|
|
| Estimated grant date fair value | $ |
|
195
|
|
|
|
|
| Weighted average remaining life |
9 years 4 months 13 days
|
|
|
|
|
|
| Option Expiration Period Twenty Four |
|
|
|
|
|
|
| Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] |
|
|
|
|
|
|
| Number of share options outstanding (in shares) |
|
|
80,000
|
|
|
|
| Number of options exercisable (in shares) |
|
|
30,000
|
|
|
|
| Exercise price (in USD per share) | $ / shares |
|
|
|
11.00
|
|
|
| Estimated grant date fair value | $ |
|
319
|
|
|
|
|
| Weighted average remaining life |
9 years 4 months 13 days
|
|
|
|
|
|
| Option Expiration Period Twenty Five |
|
|
|
|
|
|
| Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] |
|
|
|
|
|
|
| Number of share options outstanding (in shares) |
|
|
15,000
|
|
|
|
| Number of options exercisable (in shares) |
|
|
5,625
|
|
|
|
| Exercise price (in USD per share) | $ / shares |
|
|
|
11.00
|
|
|
| Estimated grant date fair value | $ |
|
63
|
|
|
|
|
| Weighted average remaining life |
9 years 4 months 28 days
|
|
|
|
|
|
| Option Expiration Period Twenty Six |
|
|
|
|
|
|
| Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] |
|
|
|
|
|
|
| Number of share options outstanding (in shares) |
|
|
200,000
|
|
|
|
| Number of options exercisable (in shares) |
|
|
50,000
|
|
|
|
| Exercise price (in USD per share) | $ / shares |
|
|
|
8.39
|
|
|
| Estimated grant date fair value | $ |
|
551
|
|
|
|
|
| Weighted average remaining life |
9 years 6 months
|
|
|
|
|
|
| Option Expiration Period Twenty Seven |
|
|
|
|
|
|
| Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] |
|
|
|
|
|
|
| Number of share options outstanding (in shares) |
|
|
44,240
|
|
|
|
| Number of options exercisable (in shares) |
|
|
11,060
|
|
|
|
| Exercise price (in USD per share) | $ / shares |
|
|
|
8.39
|
|
|
| Estimated grant date fair value | $ |
|
109
|
|
|
|
|
| Weighted average remaining life |
9 years 7 months 13 days
|
|
|
|
|
|
| Option Expiration Period Twenty Eight |
|
|
|
|
|
|
| Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] |
|
|
|
|
|
|
| Number of share options outstanding (in shares) |
|
|
13,430
|
|
|
|
| Number of options exercisable (in shares) |
|
|
1,678
|
|
|
|
| Exercise price (in USD per share) | $ / shares |
|
|
|
$ 11.65
|
|
|
| Estimated grant date fair value | $ |
|
$ 30
|
|
|
|
|
| Weighted average remaining life |
9 years 9 months
|
|
|
|
|
|